These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 9281201
1. [Free radicals in the origin and clinical manifestation of Down's syndrome]. Arbuzova SB. Tsitol Genet; 1996; 30(2):25-34. PubMed ID: 9281201 [Abstract] [Full Text] [Related]
6. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening. Leporrier N, Herrou M, Morello R, Leymarie P. BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930 [Abstract] [Full Text] [Related]
9. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States. Khoshnood B, Pryde P, Blondel B, Lee KS. Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994 [Abstract] [Full Text] [Related]
11. [The origin of an extra chromosome 21 in families of children with Down syndrome]. Davidenkova EF, Butomo IV, Kovaleva NV. Genetika; 1988 Sep; 24(9):1671-8. PubMed ID: 2974006 [Abstract] [Full Text] [Related]
12. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome]. Kjaergaard S, Hahnemann JM, Skibsted L, Jensen LN, Sperling L, Zingenberg H, Kristiansen A, Brøndum-Nielsen K. Ugeskr Laeger; 2008 Mar 31; 170(14):1152-6. PubMed ID: 18405480 [Abstract] [Full Text] [Related]
13. Previous child with trisomy 21 and abortion rate. Aymé S, Lippman A. Prog Clin Biol Res; 1985 Mar 31; 163C():15-9. PubMed ID: 3157997 [No Abstract] [Full Text] [Related]
14. [The use of oxidant-antioxidant system indices in forming groups at high genetic risk]. Arbuzova SB, Fedotova OO, Malova SA, Krasnov AV. Tsitol Genet; 1999 Mar 31; 33(4):77-80. PubMed ID: 10563382 [Abstract] [Full Text] [Related]
16. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing. Ogilvie CM, Lashwood A, Chitty L, Waters JJ, Scriven PN, Flinter F. BJOG; 2005 Oct 31; 112(10):1369-75. PubMed ID: 16167939 [Abstract] [Full Text] [Related]
17. Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies. Morris JK, Wald NJ. J Med Screen; 2007 Oct 31; 14(1):5-7. PubMed ID: 17362564 [Abstract] [Full Text] [Related]
18. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays. Spencer K. Ann Clin Biochem; 2005 Jan 31; 42(Pt 1):30-40. PubMed ID: 15802030 [Abstract] [Full Text] [Related]
19. Comparison of Nicolaides' risk evaluation for Down's syndrome with a novel software: an analysis of 1,463 cases. Schmidt P, Staboulidou I, Soergel P, Wüstemann M, Hillemanns P, Scharf A. Arch Gynecol Obstet; 2007 Jun 31; 275(6):469-74. PubMed ID: 17333228 [Abstract] [Full Text] [Related]